Literature DB >> 19830525

Can permeability measurements add to blood volume measurements in differentiating tumefactive demyelinating lesions from high grade gliomas using perfusion CT?

Rajan Jain1, Shehanaz Ellika, Norman L Lehman, Lisa Scarpace, Lonni R Schultz, Jack P Rock, Mark Rosenblum, Tom Mikkelsen.   

Abstract

Tumefactive demyelinating lesions (TDLs) can mimic a neoplasm on conventional imaging and may necessitate biopsy for diagnosis. The purpose of this study was to differentiate TDLs from high grade gliomas based on physiologic (permeability) and hemodynamic (blood volume) parameters using perfusion CT. Five patients who presented with tumefactive enhancing lesions on initial MRI that mimicked a neoplasm underwent perfusion CT. We compared the perfusion CT parameters of these patients with those of 24 patients with high grade gliomas. TDLs showed lower permeability surface area product (PS) (0.8 +/- 0.2 vs 2.4 +/- 1.4 ml/100 g/min, P-value 0.014) and lower cerebral blood volume (CBV) (1.0 +/- 0.2 vs 2.8 +/- 1.2 ml/100 g, P-value 0.006) as compared to high grade gliomas. TDLs show lower PS and CBV as compared to high grade gliomas, to which they can mimic on conventional MR imaging, due to lack of neoangiogenesis and vascular endothelial proliferation and hence perfusion CT can be used to differentiate the two entities.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19830525      PMCID: PMC8324398          DOI: 10.1007/s11060-009-0030-2

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  21 in total

1.  Abnormalities in the recirculation phase of contrast agent bolus passage in cerebral gliomas: comparison with relative blood volume and tumor grade.

Authors:  Alan Jackson; Andrea Kassner; Deborah Annesley-Williams; Helen Reid; Xiau-Ping Zhu; Kah-Loh Li
Journal:  AJNR Am J Neuroradiol       Date:  2002-01       Impact factor: 3.825

2.  Acute focal demyelinating disease simulating brain tumors: histopathologic guidelines for an accurate diagnosis.

Authors:  Y Sugita; M Terasaki; M Shigemori; K Sakata; M Morimatsu
Journal:  Neuropathology       Date:  2001-03       Impact factor: 1.906

3.  Comparison of cerebral blood volume and permeability in preoperative grading of intracranial glioma using CT perfusion imaging.

Authors:  Bei Ding; Hua Wei Ling; Ke Min Chen; Hong Jiang; Yan Bo Zhu
Journal:  Neuroradiology       Date:  2006-08-26       Impact factor: 2.804

4.  Prominent perivenular spaces in multiple sclerosis as a sign of perivascular inflammation in primary demyelination.

Authors:  Yulin Ge; Meng Law; Joseph Herbert; Robert I Grossman
Journal:  AJNR Am J Neuroradiol       Date:  2005-10       Impact factor: 3.825

5.  Multiple sclerosis: histopathologic and MR and/or CT correlation in 37 cases at biopsy and three cases at autopsy.

Authors:  G M Nesbit; G S Forbes; B W Scheithauer; H Okazaki; M Rodriguez
Journal:  Radiology       Date:  1991-08       Impact factor: 11.105

6.  Large focal tumor-like demyelinating lesions of the brain: intermediate entity between multiple sclerosis and acute disseminated encephalomyelitis? A study of 31 patients.

Authors:  J J Kepes
Journal:  Ann Neurol       Date:  1993-01       Impact factor: 10.422

7.  Comparison of cerebral blood volume and vascular permeability from dynamic susceptibility contrast-enhanced perfusion MR imaging with glioma grade.

Authors:  Meng Law; Stanley Yang; James S Babb; Edmond A Knopp; John G Golfinos; David Zagzag; Glyn Johnson
Journal:  AJNR Am J Neuroradiol       Date:  2004-05       Impact factor: 3.825

8.  Demyelinating disease versus tumor in surgical neuropathology. Clues to a correct pathological diagnosis.

Authors:  D Zagzag; D C Miller; G M Kleinman; A Abati; H Donnenfeld; G N Budzilovich
Journal:  Am J Surg Pathol       Date:  1993-06       Impact factor: 6.394

9.  Role of perfusion CT in glioma grading and comparison with conventional MR imaging features.

Authors:  S K Ellika; R Jain; S C Patel; L Scarpace; L R Schultz; J P Rock; T Mikkelsen
Journal:  AJNR Am J Neuroradiol       Date:  2007-09-24       Impact factor: 3.825

10.  Clinical and radiographic spectrum of pathologically confirmed tumefactive multiple sclerosis.

Authors:  C F Lucchinetti; R H Gavrilova; I Metz; J E Parisi; B W Scheithauer; S Weigand; K Thomsen; J Mandrekar; A Altintas; B J Erickson; F König; C Giannini; H Lassmann; L Linbo; S J Pittock; W Brück
Journal:  Brain       Date:  2008-06-05       Impact factor: 13.501

View more
  5 in total

1.  Recurrent tumefactive demyelination without evidence of multiple sclerosis or brain tumour.

Authors:  A Häne; M Bargetzi; E Hewer; M Bruehlmeier; A Khamis; U Roelcke
Journal:  J Neurol       Date:  2010-08-29       Impact factor: 4.849

Review 2.  Permeability imaging in pediatric brain tumors.

Authors:  Sandi Lam; Yimo Lin; Peter C Warnke
Journal:  Transl Pediatr       Date:  2014-07

Review 3.  Perfusion CT imaging of brain tumors: an overview.

Authors:  R Jain
Journal:  AJNR Am J Neuroradiol       Date:  2010-11-04       Impact factor: 3.825

4.  Permeability estimates in histopathology-proved treatment-induced necrosis using perfusion CT: can these add to other perfusion parameters in differentiating from recurrent/progressive tumors?

Authors:  R Jain; J Narang; L Schultz; L Scarpace; S Saksena; S Brown; J P Rock; M Rosenblum; J Gutierrez; T Mikkelsen
Journal:  AJNR Am J Neuroradiol       Date:  2011-02-17       Impact factor: 3.825

Review 5.  Hemodynamic Imaging in Cerebral Diffuse Glioma-Part A: Concept, Differential Diagnosis and Tumor Grading.

Authors:  Lelio Guida; Vittorio Stumpo; Jacopo Bellomo; Christiaan Hendrik Bas van Niftrik; Martina Sebök; Moncef Berhouma; Andrea Bink; Michael Weller; Zsolt Kulcsar; Luca Regli; Jorn Fierstra
Journal:  Cancers (Basel)       Date:  2022-03-10       Impact factor: 6.639

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.